mounjaro generic name tirzepatide Mounjaro: Uses, Dosage, Side Effects & Warnings Mounjaro 5 mg/0.5 ml (Tirzepatide)

Weight loss typically becomes more noticeable over the following weeks as doses are adjusted and the body responds to the medication

Tirzepatide is a dual GIP and GLP-1 receptor agonist, which means it activates two different hormone pathways simultaneously

Others have higher density in the brain appetite centers, making them more sensitive to the appetite-suppressing effects

The GLP-1 receptor arm is well understood at this point

To be specific: The STEP 1 trial showed 14.9% body weight loss at 68 weeks with semaglutide 2.4mg

PlexusDx's Precision Peptide Genetic Test examines your GLP1R rs6923761 variant and other key genetic markers to predict how your body responds to tirzepatide therapy